Form EFFECT Esperion Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 15, 2026 |
| Accession Number: | 0001104659-26-083007 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Falcon Is Sold for AED 2.1 Million (USD 571,000) in Abu Dhabi, Setting the World’s Highest Price Ever at Falcon Auction
- Ethereum Price Prediction: BitMine Loads Another 53,501 ETH as $3,000 Target Returns, AlphaPepe Buyers Chase Bigger Upside
- The 915 Lawyer ranks No. 1 in 2026 El Paso car accident lawyer research report
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share